ESR1 and melanoma: Although, DTIC is the preferred drug in melanoma treatment, which is used at 5–10 times the dose of tamoxifen[12], it is desirable to define a strategy to enhance the therapeutic efficacy of tamoxifen, a well known ER antagonist.